ALR Technologies, Inc. (OTCBB: ALRT)
DALLAS–(BUSINESS WIRE)–Equity Stock Analysis interview Stan Cruitt, the President of ALR Technologies (OTCBB: ALRT – News), in conjunction with the release of an Equity Stock Analysis research report authored by Kris Gupta, CFA. (http://equitystockanalysis.com)
Stan Cruitt is taking a break from his city to city conference routines in his office in Winston-Salem, North Carolina. He has headed up ALR Technologies for the last six years.
“For the last year we have made a real push to bring our message of cost savings to the healthcare management industry. We have found a receptive audience. Medication and treatment non-compliance is the second largest health problem in the United States in terms of resources consumed and we have an industry that understands our product and service supports real cost efficiencies.”
Stan’s experience in marketing research with Merck to top marketing and management positions with Ciba and Novartis haved served him well as he shares ALR Technologies message of cost efficiencies. In 1996, Newsweek and Advertising Age recognized Stan as one of the top marketers in the United States.
“The recognized reality that an additional $100 billion in healthcare costs annually results from non-compliance which by the way came from a study The New England Journal of Medicine has strongly supported our push into this field.”
“Our new Constant Health Companion(TM) is the alternative that provides lowest cost with added value features. Beyond cost, our system is portable and easy to use which both are essential elements for a system to achieve widespread usage.” We operate like a cell phone company, our real revenue stream comes from the monitoring service that is enabled by our hardware. Healthcare organizations are being pushed to develop programs to promote disease management compliance and we have the technology which allows them to do that.
“We are making serious progress that could translate to major milestones for the company and its shareholders. Speciality pharmacy groups, PBMs, Medicaid groups and health insurance payors…they are all seeing the benefits of the our Constant Health Companion system. And with our first full manufacturing run inventory scheduled for shipment in first quarter of 2007 we are focusing on market growth initiatives.”
ALR Technologies is competitive in terms of cost. The current pricing is approximately 31% lower than the next closest competitor for 1 year of services and roughly fifty percent lower than the next closest competitor in terms of product price comparisons.
Equity Stock Analysis presents ALR Technologies compelling story of a company that is establishing its presence in the newest section of the healthcare industry: Disease Management Compliance.
Equity Stock Analysis is an independent fee based research, publishing and distribution firm whose contract analyst adhere to the ethics and standards of the Association for Investment Research Management. The views expressed in this research report reflect the analyst’s personal views about the issuer and its securities. Opinions and recommendations contained in this report are submitted solely for advisory and information purposes and are not intended as an offering or a solicitation to buy or sell the securities mentioned above. The analysts are responsible only to the public and this report is not a service to the company.
To submit a company for consideration by Equity Stock Analysis, please call Lee Anderson at (214) 500-5410. For more information on Equity Stock Analysis, please visit our web site: EquityStockAnalysis.com.
We received a fee of $15,000 from a non-controlling third part (Mercom Capital Group, LLC) for one year’s coverage. We do not inform any company in advance of the nature or conclusions of our analysts’ reports in advance of paying the fee nor can a company withdraw from coverage before the expiration of the one year term. Neither the Analysts nor the company own equity or debt securities of the companies on which our contract analysts report. More information about Equity Stock Analysis policies are available at www.equitystockanalysis.com.
Contact:
Public and Investor Relations:
Mercom Capital Group, LLC, 512-828-6645
or
Equity Stock Analysis:
Lee Anderson, 214-500-5410
Source: ALR Technologies and Equity Stock Analysis
View the StockGuru Profile for ALR Technologies:
http://www.stockguru.com/profiles/alrt/
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $15,000 from a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
